Extracting Unrecognized Gene Relationships From the Biomedical Literature via Matrix Factorizations Using a Priori Knowledge of Gene Relationships by Kim, Hyunsoo & Park, Haesun
Extracting unrecognized gene relationships from the
biomedical literature via matrix factorizations using a
priori knowledge of gene relationships
Hyunsoo Kim and Haesun Park
College of Computing, Georgia Institute of Technology
801 Atlantic Drive, Atlanta, GA 30332
hskim@cc.gatech.edu, hpark@cc.gatech.edu
ABSTRACT
The construction of literature-based networks of gene-gene inter-
actions is one of the most important applications of text mining
in bioinformatics. Extracting potential gene relationships from the
biomedical literature may be helpful in building biological hypothe-
ses that can be explored further experimentally. In this paper, we
explore the utility of singular value decomposition (SVD) and non-
negative matrix factorization (NMF) to extract unrecognized gene
relationships from the biomedical literature by taking advntage of
known gene relationships. We introduce a way to incorporatea
priori knowledge of gene relationships into LSI/SVD and NMF.
In addition, we propose a gene retrieval method based on NMF
(GR/NMF), which shows comparable performance with latent s-
mantic indexing based on SVD.
Categories and Subject Descriptors
I.5.4 [Pattern Recognition]: Application—Text processing; H.3.3
[Information storage and retrieval]: Information Search and Re-
trieval—Clustering; G.1.3 [Numerical Analysis]: Numerical Lin-




Gene relationships, singular value decomposition, non-negative ma-
trix factorization
1. INTRODUCTION
Latent semantic indexing based on singular value decomposition
(LSI/SVD) [3, 2] uses the truncated singular value decomposition
as a low-rank approximation of a term-by-document matrix. Re-
cently, LSI/SVD has been applied to gene clustering so as to re-
trieve genes directly and indirectly associated with the Relin sig-
naling pathway [8]. This approach may provide us with a power-
ful tool for the functional relationship analysis of discovery-based
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genomic experiments. However, this work did not utilize a priori
knowledge of gene-gene relationships that are generally available.
Moreover, the determination of the number of factorsk used in the
reduced rank matrix is still an open problem even though it isan im-
portant parameter that determines a concept space in which gene-
documents are projected. In this paper, we suggest a method to esti-
mate the reduced rankk in LSI/SVD by taking advantage of known
gene relationships. In addition, we propose a gene retrieval method
based on non-negative matrix factorization (GR/NMF), which is
a new framework for extracting unrecognized gene relationships
from the biomedical literature.
Given a non-negative matrixA of sizem × n and a desired re-




‖A − WH‖2F , s.t. W, H ≥ 0, (1)
whereW ∈ Rm×k is a basis matrix,H ∈ Rk×n is a reduced
dimensional representation ofA, andW,H ≥ 0 means that all
elements ofW andH are non-negative. NMF does not provide
us with a unique solution if we can find a full rank square matrix
X such thatA = WXX−1H, WX ≥ 0, X−1H ≥ 0 [14]. NMF
gives us more direct interpretation than PCA due to non-subtractive
combinations of non-negative basis vectors. Also, some practical
problems require non-negative basis vectors. For example,pix ls
in digital images, term frequencies in text mining, and chemical
concentrations in bioinformatics are typically non-negative [7]. It
has been successfully applied to many problems including text data
mining [14, 21] and gene expression data analysis [12, 6]. Non-
negative dimension reduction is desirable for handling themassive
quantity of high-dimensional data that require non-negative con-
straints. The determination of the reduced dimensionk a d the ini-
tialization ofW andH are open problems. Some NMF algorithms
[14, 15, 9] require that bothW andH be initialized, while NMF
based alternating non-negativity-constrained least squares that we
describe in this paper only requires the initialization ofH . We ini-
tialized a part of the matrixH by incorporating a known cluster
structure and determined the reduced dimensionk that can well
capture known gene relationships.
2. GENE-DOCUMENT COLLECTION
To identify unrecognized gene relationships forn genes, a term-
by-genedocument matrixA of sizem × n is generated following
the scheme proposed in [8]. Each gene-document, which is repre-
sented as a column in the matrixA, is generated by concatenation
of all titles and abstracts of the PubMed IDs cross-referenced in the
human, mouse, and rat Entrez Gene IDs for each gene.
We applied common filtering techniques (e.g. removal of com-
mon words, removal of words that are too short or too long,etc.)
for the purpose of reducing the size of the term dictionary. Stem-
ming was also applied. Them × n term-by-genedocument ma-
trix A = [aij ] was provided by using a log-entropy weighting
scheme [2]. The elements ofA are often assigned two-part values
aij = lij ∗ gi, wherelij is the local weight for thei-th term in the
j-th gene-document, andgi is the global weight for thei-th term.
The local weightlij and the global weightgi can be computed as
lij = log2(1 + fij),
















wherefij is the frequency of thei-th term in thej-th gene-document,
pij is the probability of thei-th term occurring in thej-th gene-
document, andn is the number of gene-documents in the collec-
tion.
A gene-document vectorai (thei-th column ofA) can be easily
compared with another gene-document vectorsaj (1 ≤ j ≤ n)
in the full dimensional space. The similarity scores between two







Gene-document vectors having the higher cosine values are deemed
more relevant to each other.
In this gene retrieval method, a query gene vector is one of col-
umn vectors ofA. This method tries to retrieve genes relevant to
the given query gene. In order to compare gene retrieval methods
quantitatively, we used the following performance measure. We
defined the relevant genes, which include the query gene itself a
well as genes related with the query gene. The recall and precision
are defined as
recall=




|{relevant genes} ∩ {retrieved genes}|
|{retrieved genes}|
.
The weighted harmonic mean of precision and recall, the traditional
F -measure is defined as
F -measure=
2 ∗ recall∗ precison
recall+ precision
.
In this paper, total of 50 genes were considered in three broad
categories: (1) Alzheimer’s disease; (2) cancer; (3) development
(see Table 1). These 50 genes are the same genes as those used
in [8]. For each Enrez Gene ID, we downloaded up to 10 most
recent titles and abstracts, which were available as of July, 2006.
Table 6 shows Entrez Gene IDs for human, mouse, and rat and the
number of PubMed citations for each gene. We built a term-by-
genedocument matrixA of size8, 316 × 50 in the form of MAT-
LAB sparse arrays generated by Text to Matrix Generator (TMG)
[25].
3. REDUCED RANK ESTIMATION
FOR GENE RETRIEVAL VIA LSI/SVD
LSI is based on the assumption that there is some underlying
latent semantic structure in the term-by-genedocument matrix that
Table 1: The genes considered in the data set. The letters
‘A’,‘C’ and ‘D’ in brackets show the relation with Alzheimer ’s
disease, cancer, development, respectively.
A2M(A) APBA1(A) APBB1(A) APLP1(A)
APLP2(A) APOE(A) APP(A) LRP1(A)
MAPT(A) PSEN1(A) PSEN2(A) ABL1(C)
BRCA1(C) BRCA2(C) DNMT1(C) EGFR(C)
ERBB2(C) ETS1 (C) FOS (C) FYN(C)
KIT(C) MYC(C) NRAS(C) SHC1(C)
SRC(C) TP53(C) TGFB1(D) ATOH1(D)
CDK5(D) CDK5R1(D) CDK5R2(D) DAB1(D)
DLL1(D) GLI(D) GLI2(D) GLI3(D)
JAG1(D) LRP8(D) NOTCH1(D) PAX2(D)
PAX3(D) PTCH(D) RELN(D) ROBO1(D)
SHH(D) SMO(D) VLDLR(D) WNT1(D)
WNT2(D) WNT3(D)
is corrupted by the wide variety of words used in gene-documents.
This is referred to as the problem of polysemy and synonymy. The
basic idea is that if two gene-documents represent the same topic,
they will share many associating words, and they will have very
close semantic structures after dimension reduction via SVD. In
LSI/SVD, if the matrixA has its SVD,
A = UΣV,




is considered, where the columns ofUk are the leadingk left sin-
gular vectors,Σk is ank × k diagonal matrix with thek largest
singular values in nonincreasing order along its diagonal,and the
columns ofVk are the leadingk right singular vectors. Then,ΣkV Tk
is the reduced dimensional representation ofA, or equivalently, a
gene-document vectora ∈ Rm×1 can be represented in thek-
dimensional space aŝa = UTk a. Then, the similarity scores be-
tween two gene-documents (âi andâj ) in thek-dimensional space













Gene-documents having the higher cosine values in the reducedk-
dimensional space are deemed more relevant to each other.
Here, we suggest a method to estimate the reduced rankk i
LSI/SVD in order to retrieve unrecognized genes related with a
query gene. If we can capture known gene-gene relationshipsin
the reduced dimensional space obtained from LSI/SVD, we expct
that the low-rank representations of gene-document vectors w uld
be reliable to extract other gene relationships as well. This reduced
rank k estimation scheme computes the following recall (r̃), pre-
cision (̃p), andF̃ -measure only from known genes relevant to the
given query gene:
r̃ =








2 ∗ r̃ ∗ p̃
r̃ + p̃
, (3)
Table 2: Genes directly and indirectly associated with the Reelin signal pathway. The cosine similarities between RELNand genes
in the full space and the reduced dimensional space obtainedfrom NMF are also presented. (n/a: not applicable)
Gene PubMed co-citation Symbol match Full space NMF (k = 3)
# co-citation Rank # match Rank cos θ Rank cos θ Rank
Genes directly associated with the Reelin signaling (five genes)
RELN n/a - n/a - 1.0000 1 1.0000 1
DAB1 9 1 47 1 0.4770 2 0.9997 2
LRP8 2 2 1 7 0.2981 3 0.9955 7
VLDLR 2 2 9 2 0.2552 4 0.9982 6
FYN 1 5 4 4 0.1760 8 0.9853 8
Genes indirectly associated with the Reelin signaling (sixgenes)
CDK5 2 2 3 6 0.1847 7 0.9997 2
CDK5R1 1 5 0 - 0.1972 5 0.9997 2
CDK5R2 1 5 0 - 0.1927 6 0.9997 2
APOE 0 - 0 - 0.1209 14 0.7489 10
SRC 1 5 5 3 0.1256 11 0.8946 9
MAPT 0 - 0 - 0.1209 13 0.6516 11
Table 3: Known and unrecognized genes associated with the Alzheimer’s disease pathway. The cosine similarities between APP and
genes in the full space and the reduced dimensional space obtained from NMF are also presented. (n/a: not applicable)
Gene PubMed co-citation Symbol match Full space NMF (k = 3)
# co-citation Rank # match Rank cos θ Rank cos θ Rank
Known genes associated with the Alzheimer’s disease pathway (eight genes)
APP n/a - n/a - 1.0000 1 1.0000 1
APBB1 0 - 97 1 0.1947 4 0.9977 3
LRP1 0 - 12 8 0.1166 14 0.7699 8
APOE 0 - 0 - 0.1338 8 0.4694 10
A2M 0 - 1 10 0.0890 21 0.4057 11
PSEN1 2 1 37 5 0.3108 2 0.9977 3
PSEN2 0 - 18 6 0.2036 3 0.9971 7
MAPT 0 - 1 10 0.1830 5 0.7012 9
Unrecognized genes associated with the Alzheimer’s disease p thway (three genes)
APLP1 0 - 95 2 0.1623 7 0.9977 3
APLP2 0 - 85 3 0.1644 6 0.9977 3
APBA1 0 - 54 4 0.1338 9 0.9991 2
for variousk values. It chooses the smallestk hat shows the high-
estF̃ -measure value in order to retrieve unrecognized genes related
to the given query gene.
4. NMF BASED ON ALTERNATING
NON-NEGATIVITY-CONSTRAINED
LEAST SQUARES
In this section, we describe an algorithm for NMF based on al-
ternating non-negativity-constrained least squares (NMF/ANNLS).
Given a non-negative matrixA ∈ Rm×n, NMF/ANNLS starts with
the initialization ofH ∈ Rk×n with non-negative values. Then, it
iterates the following ANNLS until convergence:
min
W
‖HT W T − AT ‖2F , s.t. W ≥ 0, (4)
which fixesH and solves the optimization with respect toW , and
min
H
‖WH − A‖2F , s.t. H ≥ 0, (5)
which fixesW and solves the optimization with respect toH . Paatero
and Tapper [20] originally proposed using a constrained alternating
least squares algorithm to solve Eq. (1). Lin [18] discussedabout
the convergence property of alternating non-negativity-constrained
least squares and showed that any limit point of the sequence(W ,H)
generated by alternating non-negativity-constrained least squares is
a stationary point of Eq. (1). After convergence, the columns of the
basis matrixW are normalized to unitL2-norm and the rows ofH
are adjusted so that the approximation error is not changed.When
k < m, the non-negative low-rank representation ofA is given by
H . Here, we adopt a fast algorithm for large scale non-negativity-
constrained least squares (NNLS) problems [24] to solve Eqns. (4-
5). Bro and de Jong [5] made a substantial speed improvement to
Lawson and Hanson’s algorithm [13] for large scale NNLS prob-
lems. Van Benthem and Keenan [24] devised an algorithm that
further improves the performance of NNLS for multivariate data.
This algorithm deals with the following NNLS optimization prob-
lem givenB ∈ Rm×k andA ∈ Rm×n:
min
G
‖BG − A‖2F , s.t. G ≥ 0,
whereG ∈ Rk×n is a solution. It is based on the active/passive set
method. More detailed explanations of this algorithm can befound
in [24].
5. GENE RETRIEVAL VIA NMF
(GR/NMF)
In this section, we describe a gene retrieval method based on
NMF (GR/NMF) including the initialization ofH and the reduced
dimensionk selection scheme.
Table 4: Influence of rank k on the retrieval of genes directly
and indirectly associated with the Reelin signal pathway. Re-
call, precision, andF -measure were computed when 10 genes
were retrieved. *Reduced dimensionk obtained from the k-
selection scheme using only genes directly associated withthis
pathway.
k Recall Precision F -measure
LSI/SVD 2 0.5455 0.6000 0.5714
3* 0.8182 0.9000 0.8571
4 0.8182 0.9000 0.8571
5 0.8182 0.9000 0.8571
6 0.6364 0.7000 0.6667
10 0.6364 0.7000 0.6667
20 0.7273 0.8000 0.7619
30 0.7273 0.8000 0.7619
40 0.7273 0.8000 0.7619
50 0.7273 0.8000 0.7619
GR/NMF 2 0.3636 0.4000 0.3810
3* 0.9091 1.0000 0.9524
4 0.9091 1.0000 0.9524
5 0.9091 1.0000 0.9524
6 0.9091 1.0000 0.9524
10 0.6364 0.7000 0.6667
20 0.5455 0.6000 0.5714
5.1 A method for initialization
Most of NMF algorithms require to initialize bothW and H ,
whereas NMF/ANNLS described in this paper needs to initialize
only H . In our approach, we incorporate a priori knowledge of
gene relationships into the initialization ofH . A gene-document is
represented as a linear combination of basis vectors. For gene clus-
tering by NMF, gene-documents that are dominated by the same
basis vector belong to the same cluster. Here, we propose thefol-
lowing NMF initialization strategy. The elements of the first ow
of the initial matrixH ∈ Rk×n are set to 1 only if columns are
corresponding to a set of known genesSg related with one another,
otherwise 0. For the other rows ofH , the elements are set to 0 only
if columns are corresponding toSg, otherwise random numbers
∈ (0.25, 0.75).
For example, we know that RELN is related with DAB1, LRP8,
VLDLR, and FYN. Thus, the elements of the first row ofH have 1
only if columns are corresponding to a set of genesSg = {RELN,
DAB1, LRP8, VLDLR, FYN}, otherwise 0. The elements of the
other rows ofH have 0 only if columns are corresponding toSg,
otherwise random numbers∈ (0.25, 0.75). Let us assume that
the 4th, 5th, 6th, 7th, and 8th columns ofH are corresponding to
RELN, DAB1, LRP8, VLDLR, and FYN. Then, whenk = 3, we




0 0 0 1 1 1 1 1 0 · · · 0
• • • 0 0 0 0 0 • · · · •
• • • 0 0 0 0 0 • · · · •
1
A ,
where the values in the location of• are random numbers. The
columns of the initial matrixH are normalized to unitL2-norm.
This initial matrixH contains a priori cluster structure.
5.2 Gene retrieval
NMF/ANNLS is used to obtain the finalW andH from the ini-
tial matrix H . Convergence is tested at every five iterations. The






































Figure 1: Three-dimensional representations of 50 genes, which
were obtained from NMF (k = 3) using an initial matrix H
built from genes directly associated with Reelin signalingpath-
way. The j-th gene is located at (h1j ,h2j ,h3j ), where H ∈
R
3×50 = [hij ]. (A red circle: RELN; A red circle and blue
diamonds: genes associated with the Reelin signaling pathway;
Black dots: other genes)




wherefprev andfcurr are the Frobenius norms in the previous and
current convergence tests respectively.
The final matrixH ∈ Rk×n contains the low-rank representa-
tion of the term-by-genedocument matrixA. Hence, the similarity








wherehj is thej-th column of the final matrixH . Genes having
the higher cosine values in thek-dimensional space are deemed
more relevant to each other.
NMF can generate different finalH matrices because of the ran-
dom numbers in the initial matrixH . Therefore, it is natural to
repeat NMF with different initial matrices to obtain finalH matri-
ces. GR/NMF selects one of the finalH matrices, which generates
the highestF̃ -measure value using only known genes related with
a query gene (see Eq. (3)). If there are several finalH matrices
that yield the same maximal̃F -measure value, it chooses one pro-
ducing the highest average of cosine values between the query gene
and other known genes related with the query gene.
5.3 Reduced rank estimation for GR/NMF
The determination of the reduced rankk is also an open problem
in NMF. As thek-selection scheme for LSI/SVD, we can estimate
the reduced rank for GR/NMF by making use of known gene-
gene relationships. The reducedk-dimensional representations of
n gene-documents are obtained from NMF. Then,F̃ -measure is
calculated only from known genes relevant to a query gene, aft r
Table 5: Influence of rank k on the retrieval of genes associated
with the Alzheimer’s disease pathway. Recall, precision, and
F -measure were computed when 10 genes were retrieved. *Re-
duced dimensionk obtained from the k-selection scheme using
only known genes associated with this pathway.
k Recall Precision F -measure
LSI/SVD 2 0.4545 0.5000 0.4762
3 0.8182 0.9000 0.8571
4* 0.9091 1.0000 0.9524
5 0.9091 1.0000 0.9524
6 0.8182 0.9000 0.8571
10 0.7273 0.8000 0.7619
20 0.7273 0.8000 0.7619
30 0.7273 0.8000 0.7619
40 0.6364 0.7000 0.6667
50 0.8182 0.9000 0.8571
GR/NMF 2 0.4545 0.5000 0.4762
3* 0.9091 1.0000 0.9524
4 0.9091 1.0000 0.9524
5 0.9091 1.0000 0.9524
6 0.9091 1.0000 0.9524
10 0.9091 1.0000 0.9524
20 0.8182 0.9000 0.8571
retrieving genes by cosine similarities in the reducedk-dimensional
space. Even with singlek value, NMF can generate different̃F -
measure values owing to the random numbers in the initial matrix
H . Thus, to decide ãF -measure value for eachk, thek-selection
scheme selects the highestF̃ -measure value after computing̃F -
measure values with different initial matrices. It determines F̃ -
measure values for variousk and then chooses the smallest reduced
rankk that produces the highest̃F -measure value.
6. RESULTS AND DISCUSSION
For evaluation of various methods, we study two biological path-
ways: (1) Reelin signaling pathway and (2) Alzheimer’s disease
pathway. We try to extract unrecognized gene-gene relationsh ps
from the biomedical literature by taking advantage of knownge e
relationships.
6.1 Reelin signaling pathway
Reelin is a large extracellular protein that controls neuronal po-
sitioning, formation of laminated structures (including the cerebel-
lum) and synapse structure in the developing central nervous sys-
tem [22, 23]. Reelin binds directly to lipoprotein receptors, the very
low-density lipoprotein receptor (VLDLR) and the apolipopr tein
E receptor-2 (ApoER2), and induces tyrosine phosphorylation of
the cytoplasmic adapter protein Disabled-1 (Dab1) by fyn tyrosine
kinase. APOER2 is a gene alias name of LRP8. By using these
knowledge, we chose five genes directly associated with Reelin sig-
naling pathway,i.e. {RELN, DAB1, LRP8, VLDLR, FYN}.
We will examine if we can find the following indirect gene re-
lationships by using above knowledge. Dab1 is phosphorylated on
serine residues by cyclin-dependent kinase 5 (Cdk5) [11]. The pro-
teins encoded by CDK5R1 (p35) and CDK5R2 (p39) are neuron-
specific activators of Cdk5. They associate with Cdk5 to form
an active kinase. Apolipoprotein E (ApoE) is a small lipophilic
plasma protein and a component of lipoproteins such as chylomi-
cron remnants, very low density lipoprotein (VLDL), and higden-
sity lipoprotein (HDL). The ApoER2 is involved in cellular recog-






































Figure 2: Three-dimensional representations of 50 genes, which
were obtained from NMF (k = 3) using an initial matrix H
built from known genes associated with the Alzheimer’s dis-
ease pathway. Thej-th gene is located at (h1j ,h2j ,h3j ), where
H ∈ R3×50 = [hij ]. (A red circle: APP; A red circle and blue
diamonds: genes associated with the Alzheimer’s disease path-
way; Black dots: other genes)
teraction of Reelin with its receptors. The Src related family em-
ber fyn tyrosine kinase mediates the effect of Reelin on Dab1[1,
4]. MAPT encodes the microtubule-associated protein tau. Cdk5 is
one of the major kinases that phosphorylates tau [16]. MAPT gene
mutations have been associated with several neurodegenerative dis-
orders such as Alzheimer’s disease, Pick’s disease, frontotemporal
dementia, cortico-basal degeneration and progressive supran clear
palsy. The six genes indirectly associated with the Reelin sig aling
pathway are CDK5, CDK5R1, CDK5R2, APOE, SRC, and MAPT.
6.2 Alzheimer’s disease pathway
We obtained the Alzheimer’s disease pathway from KEGG path-
way database [10]. From this pathway, we can overview a gen-
eral picture of the Alzheimer’s disease pathway. Amyloid beta
precursor protein (APP) encodes a cell surface receptor andtr s-
membrane precursor protein that is cleaved by secretases toform a
number of peptides. The pathway includes{APP, APBB1, LRP1,
APOE, A2M, PSEN1, PSEN2, MAPT} among our 50 genes. These
eight genes are known genes associated with the Alzheimer’sdis-
ease pathway.
However, we cannot guarantee that the pathway contains all in-
formation regarding the Alzheimer’s disease. We will examine if
we can find the following unrecognized knowledge from above
known knowledge. Amyloid beta precursor-like protein 1 (APLP1)
affects the endocytosis of APP and makes more APP available for
α-secretase cleavage [19]. Site-specific proteolysis of theamyloid-
beta precursor protein (APP) by BACE 1 andγ-secretase, a central
event in Alzheimer disease, releases a large secreted extrac llul r
fragment (called APP(S)), peptides of 40-43 residues derived from
extracellular and transmembrane sequences (Abeta), and a short in-
tracellular fragment (APP intracellular domain) that may function
as a transcriptional activator in a complex with the adaptorr tein
Fe65 and the nuclear protein Tip60. APP is closely related toAPP-
like protein (APLP) 1 and APLP2, and similar to APP, APLP1 and
APLP2 are also cleaved by BACE 1 [17]. Amyloid beta precur-
sor protein-binding, family A, member 1 (APBA1) stabilizesAPP
and inhibits production of proteolytic APP fragments including the
Abeta peptide that is deposited in the brains of Alzheimer’sdis-
ease patients. Some of knowledge about genes is from the gene
summary entries in Entrez Gene database. The three unrecognized
genes associated with the Alzheimer’s disease pathway are APLP1,
APLP2, and APBA1.
6.3 Performance comparison
For performance comparison, we tested two additional reference
methods to identify unrecognized gene-gene relationships. The
first method counts the number of shared PubMed citations cross-
referenced in the Entrez Gene IDs for each gene. For the Reelin
signaling pathway, we counted the number of PubMed co-citations
between RELN and other genes. For the Alzheimer’s disease path-
way, we counted the number of PubMed co-citations between APP
and other genes. If a paper is cross-referenced in two genes,the
two genes are likely to have a direct or indirect association. The
larger number of co-citations provides us with the more probable
relationship between two genes, which may be a direct or indiect
association. Provided we already knew genes directly associated
with a pathway, we can find genes indirectly associated with the
pathway. In Table 2, the number of PubMed co-citations betwen
RELN and DAB1 was 9. Even though this method could not find
the some indirect relationships,i.e. (RELN - APOE) and (RELN
- MAPT), it could find most of direct and indirect relationships in
the Reelin signaling pathway. However, it found only a knownre-
lationship (APP - PSEN1) in the Alzheimer’s disease pathway(see
Table 3). It cannot suggest potential gene relationships ifthey do
not have co-citations.
The second method counts the frequency of gene symbol ‘gene-
B’ in the gene-document of gene-A, and the frequency of gene sym-
bol ‘gene-A’ in the gene-document of gene-B to find the relation-
ship between gene-A and gene-B. For examples, we searched for
a symbol ‘DAB1’ in RELN gene-document and a symbol ‘RELN’
in DAB1 gene-document in order to find a relationship of (RELN-
DAB1). The total frequency of symbol-match for (RELN - DAB1)
was 47. Though this method could find all direct relationship,
it could not find most of indirect relationships except (RELN-
CDK5) and (RELN - SRC) in the Reelin signaling pathway. This
low recall problem is primarily due to inconsistencies in gee sym-
bol usage in the literature. It could not find a known relationship
(APP - APOE) in the Alzheimer’s disease pathway.
In contrast to these two reference methods, our gene retrieval
method based on NMF could extract most of direct and indirect
gene-gene relationships by using cosine similarity measure in the
reduced dimensional space. We ranked genes by cosine similarity
with a query gene RELN for the Reelin signaling pathway. The
higher cosine similarity provides us with the more probablerela-
tionship between two genes, which may be a direct or indirectas-
sociation. In the full dimensional space, the ranks of two indirect
relationships ((RELN - APOE) and (RELN - MAPT)) were 14 and
13, which were larger than those obtained from GR/NMF. APP was
used as a query gene for the Alzheimer’s disease pathway. In the
full dimensional space, the ranks of two known relationship((APP
- LRP1) and (APP - A2M)) were 14 and 21. In the reduced dimen-
sional space obtained from NMF, the ranks were reduced so that we
could capture the relationships. NMF (k = 3) can also be used to
visualize genes in the three dimensional space when it can retriev
most of known relationships. Figure 1 shows gene relationships
in the Reelin signaling pathway. Figure 2 illustrates gene relation-
ships in the Alzheimer’s disease pathway. By using different ini-
tializations ofH , we could focus on the specific gene relationships
in the different pathways.
The proposed NMF initialization scheme was evaluated by re-
trieving genes associated with the Alzheimer’s disease pathway
in the reduced three-dimensional space obtained from NMF with
k = 3. After computing NMF with different initializations, we
obtainedF -measure values when 10 genes were retrieved. From
50 different random initializations, NMF could produce themaxi-
mal F -measure value (0.9524) only 15 times. Typically, NMF is
sensitive to the random initialization since it converges only to a
local minimum. On the other hand, by using the proposed initial-
ization scheme, NMF could achieve the maximalF -measure value
36 times. Using known biological knowledge, we could improve
probability that NMF converges to a solution on which well reflects
the known knowledge. In addition, since the convergence crit rion
Eq. (6) is sometimes not enough for true convergence, fastercon-
vergence by the proposed NMF initialization scheme is requir d.
Tables 4 and 5 show the influence of the reduced dimensionk on
the LSI/SVD and GR/NMF retrieval performance. Recall, preci-
sion, andF -measure were computed when 10 genes were retrieved.
Both cases showed that smallk was enough to generate highF -
measure values. GR/NMF showed comparable performance with
LSI/SVD. By using thek-selection scheme in LSI/SVD, we de-
cidedk = 3 for the Reelin signaling pathway andk = 4 for the
Alzheimer’s disease pathway. For NMF, we decidedk = 3 for both
pathways. Tables 4 and 5 show that LSI/SVD and GR/NMF could
well retrieve indirect or unrecognized genes atk selected by this
scheme.
6.4 Practical applications
The proposed LSI/SVD and GR/NMF can elucidate unrecog-
nized gene-gene interactions (i.e. edges in a gene interaction graph)
from some known gene relationships. There are several typesof the
identified gene-gene interactions. Firstly, a gene relationship iden-
tified by our methods can be a completely novel direct gene-gene
interaction so that it needs to be confirmed by wet-laboratory bio-
chemical experiments. Secondly, it can be an indirect gene-gene
interaction implicit in a priori knowledge. For instance, if gene-
A activates gene-B and gene-B inhibits gene-C, then gene-A and
gene-C have an indirect gene-gene interaction. However, onneed
to be careful since there is still a possibility that gene-A and gene-C
have a direct gene-gene interaction. Thirdly, it can be an explic-
itly known direct gene-gene interaction that is available in public
databases although it was not recognized by users in advance.
7. CONCLUSIONS
In this paper, we have shown the utility of SVD and NMF so as to
extract unrecognized gene-gene relationships from the biomedical
literature. We have introduced a way to incorporate a prioriknowl-
edge into LSI/SVD and NMF in order to retrieve unrecognized
documents related with a query document. Specifically, we hav
established a reduced rankk estimation scheme for LSI/SVD and
GR/NMF, which is generally applicable to information retrival us-
ing SVD and NMF when there exists some known relationships
between a query document and other documents. The proposed
GR/NMF takes advantage of a priori knowledge of cluster struc-
ture in its initialization step. It could retrieve unrecognized genes
by using known genes associated with a biological pathway, which
showed comparable performance with LSI/SVD. Extracting poten-
tial gene relationships from the biomedical literature maybe help-
ful in building biological hypotheses that can be explored further
experimentally.
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Table 6: The number of PubMed citations associated with Entrez Gene IDs for each gene
Enrez Gene ID The number of PubMed citations
Symbol Gene description Human Mouse Rat Human Mouse Rat Total
A2M alpha-2-macroglobulin 2 232345 24153 10 10 10 30
ABL1 v-abl Abelson murine leukemia viral oncogene homolog 1 25 11350 311860 10 10 4 24
APBA1 amyloid beta precursor protein-binding, family A, meber 1 320 108119 83589 10 2 6 18
APBB1 amyloid beta precursor protein-binding, family B, meber 1 322 11785 29722 10 10 7 27
APLP1 amyloid beta precursor-like protein 1 333 11803 2957210 10 2 22
APLP2 amyloid beta precursor-like protein 2 334 11804 2538210 10 5 25
APOE apolipoprotein E 348 11816 25728 10 10 8 28
APP amyloid beta precursor protein 351 11820 54226 10 10 10 30
ATOH1 atonal homolog 1 (Drosophila) 474 11921 - 6 10 - 16
BRCA1 breast cancer 1, early onset 672 12189 24227 10 10 6 26
BRCA2 breast cancer 2, early onset 675 - 25082 10 - 3 13
CDK5 cyclin-dependent kinase 5 1020 12568 140908 10 10 10 30
CDK5R1 cyclin-dependent kinase 5, regulatory subunit 1 (p35) 8851 12569 116671 10 10 10 30
CDK5R2 cyclin-dependent kinase 5, regulatory subunit 2 (p39) 8941 12570 - 10 10 - 20
DAB1 disabled homolog 1 (Drosophila) 1600 13131 266729 10 10 4 24
DLL1 delta-like 1 (Drosophila) 28514 13388 84010 10 10 2 22
DNMT1 DNA (cytosine-5-)-methyltransferase 1 1786 13433 84350 10 10 3 23
EGFR epidermal growth factor receptor 1956 13649 24329 10 10 10 30
ERBB2 v-erb-b2 erythroblastic leukemia viral oncogene homolog 2 2064 13866 24337 10 10 10 30
ETS1 v-ets erythroblastosis virus E26 oncogene homolog 1 2113 23871 24356 10 10 10 30
FOS v-fos FBJ murine osteosarcoma viral oncogene homolog 2353 14281 24371 10 10 10 30
FYN FYN oncogene related to SRC, FGR, YES 2534 14360 25150 10 10 10 30
GLI glioma-associated oncogene homolog 1 2735 14632 14058910 10 1 21
GLI2 GLI-Kruppel family member GLI2 2736 14633 - 10 10 - 20
GLI3 GLI-Kruppel family member GLI3 2737 14634 140588 10 10 1 21
JAG1 jagged 1 (Alagille syndrome) 182 16449 29146 10 10 5 25
KIT feline sarcoma viral oncogene homolog 3815 16590 64030 10 10 8 28
LRP1 low density lipoprotein-related protein 1 4035 16971 - 10 10 - 20
LRP8 low density lipoprotein receptor-related protein 8 7804 16975 - 10 10 - 20
MAPT microtubule-associated protein tau 4137 17762 29477 10 10 10 30
MYC v-myc myelocytomatosis viral oncogene homolog (avian) 4609 17869 24577 10 10 10 30
NOTCH1 Notch homolog 1, translocation-associated (Drosophila) 4851 18128 25496 10 10 10 30
NRAS neuroblastoma RAS viral (v-ras) oncogene homolog 489318176 24605 10 10 6 26
PAX2 paired box gene 2 5076 18504 - 10 10 - 20
PAX3 paired box gene 3 (Waardenburg syndrome 1) 5077 18505 114502 10 10 2 22
PSEN1 presenilin 1 (Alzheimer disease 3) 5663 19164 29192 10 10 10 30
PSEN2 presenilin 2 (Alzheimer disease 4) 5664 19165 81751 10 10 10 30
PTCH patched homolog (Drosophila) 5727 19206 89830 10 10 3 23
RELN reelin 5649 19699 24718 10 10 10 30
ROBO1 roundabout, axon guidance receptor, homolog 1 6091 19876 58946 10 10 2 22
SHC1 Src homology 2 domain containing transforming protein1 6464 20416 85385 10 10 10 30
SHH sonic hedgehog homolog (Drosophila) 6469 20423 29499 10 10 10 30
SMO smoothened homolog (Drosophila) 6608 20596 - 10 9 - 19
SRC v-src sarcoma viral oncogene homolog 6714 20779 83805 10 10 10 30
TGFB1 transforming growth factor, beta 1 7040 21803 59086 10 10 10 30
TP53 tumor protein p53 (Li-Fraumeni syndrome) 7157 22059 2484 10 10 10 30
VLDLR very low density lipoprotein receptor 7436 22359 25696 10 10 5 25
WNT1 wingless-type MMTV integration site family, member 1 7471 22408 24881 10 10 5 25
WNT2 wingless-type MMTV integration site family member 2 7472 22413 114487 10 10 6 26
WNT3 wingless-type MMTV integration site family, member 3 7473 22415 24882 8 10 4 22
